Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 34028504.
- Also identified by DOI 10.1001/jamainternmed.2021.2209 and PMC identifier 8145157.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This follow-up study of the CORIMUNO-TOCI-1 randomized clinical trial examines the association between survival and C-reactive protein levels in patients hospitalized with COVID-19 who were treated with tocilizumab.
Medical subject headings
- Antibodies, Monoclonal, Humanized
- Severity of Illness Index
- COVID-19 Drug Treatment